| Literature DB >> 30169327 |
Zikuan Song1,2, Haoyu Wang1,2, Xiaotong Yin1,2, Pengchi Deng3, Wei Jiang1.
Abstract
Recently, nuclear magnetic resonance spectroscopy (NMR)-based metabolomics analysis and multivariate statistical techniques have been incorporated into a multidisciplinary approach to profile changes in small molecules associated with the onset and progression of human diseases. The purpose of these efforts is to identify unique metabolite biomarkers in a specific human disease so as to (1) accurately predict and diagnose diseases, including separating distinct disease stages; (2) provide insights into underlying pathways in the pathogenesis and progression of the malady and (3) aid in disease treatment and evaluate the efficacy of drugs. In this review we discuss recent developments in the application of NMR-based metabolomics in searching disease biomarkers in human blood samples in the last 5 years.Entities:
Keywords: biomarker; blood; metabolomics; nuclear magnetic resonance spectroscopy (NMR)
Mesh:
Substances:
Year: 2019 PMID: 30169327 DOI: 10.1515/cclm-2018-0380
Source DB: PubMed Journal: Clin Chem Lab Med ISSN: 1434-6621 Impact factor: 3.694